EDAP TMS S.A. Cash Flow Conversion Efficiency

Latest as of June 2026: 1.143x

EDAP TMS S.A. cash flow conversion efficiency. Based on the latest financial reports, EDAP TMS S.A. (FOCL) has a cash flow conversion efficiency ratio of 1.143x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.69 Million) by net assets ($-3.23 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of EDAP TMS S.A. (2006–2025)

Cash flow conversion efficiency of EDAP TMS S.A. from 2006 to 2025. This chart illustrates how EDAP TMS S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View EDAP TMS S.A. stock price for real-time trading data and today's change.

EDAP TMS S.A. Cash Flow Conversion Ratio Explained

EDAP TMS S.A. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

EDAP TMS S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of EDAP TMS S.A. ranked by their cash flow conversion efficiency. Also see EDAP TMS S.A. (FOCL) total market value for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Vivozon Healthcare Inc
KQ:082800
-0.011x
WEST RED LAKE GOLD MINES
F:UJ0
0.167x
Formuepleje Limittellus
CO:FPILIM
N/A
Dynacor Gold Mines Inc.
TO:DNG
0.011x
Chiang Mai Ram Medical Business Public Company Limited
BK:CMR
0.009x
Map Boga Adiperkasa Tbk PT
JK:MAPB
0.094x
POLARIS RENEWABLE ENERGY
F:N4T
N/A
Powerwell Holdings Bhd
KLSE:0217
0.106x

Annual Cash Flow Conversion Efficiency for EDAP TMS S.A. (2006–2025)

The table below shows the annual cash flow conversion efficiency of EDAP TMS S.A. from 2006 to 2025. Review FOCL free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $19.41 Million $-16.46 Million -0.848x -144.36%
2024-12-31 $42.35 Million $-14.69 Million -0.347x -37.49%
2023-12-31 $62.88 Million $-15.87 Million -0.252x -507.06%
2022-12-31 $76.45 Million $-3.18 Million -0.042x -145.03%
2021-12-31 $56.92 Million $5.26 Million 0.092x +37.06%
2020-12-31 $33.46 Million $2.25 Million 0.067x -49.46%
2019-12-31 $31.91 Million $4.25 Million 0.133x +1818.87%
2018-12-31 $29.73 Million $206.46K 0.007x +106.33%
2017-12-31 $31.46 Million $-3.45 Million -0.110x -313.56%
2016-12-31 $26.04 Million $1.34 Million 0.051x -44.85%
2015-12-31 $15.93 Million $1.48 Million 0.093x +228.02%
2014-12-31 $18.49 Million $-1.35 Million -0.073x +71.96%
2013-12-31 $12.79 Million $-3.32 Million -0.259x -1233.87%
2012-12-31 $10.76 Million $-209.26K -0.019x +78.68%
2011-12-31 $11.31 Million $-1.03 Million -0.091x +78.44%
2010-12-31 $11.94 Million $-5.05 Million -0.423x -49.33%
2009-12-31 $18.05 Million $-5.11 Million -0.283x -0.32%
2008-12-31 $23.90 Million $-6.75 Million -0.282x -59.14%
2007-12-31 $21.20 Million $-3.76 Million -0.177x -87.79%
2006-12-31 $25.45 Million $-2.41 Million -0.095x --

About EDAP TMS S.A.

NASDAQ:FOCL USA Medical Distribution
Market Cap
$156.87 Million
Market Cap Rank
#17329 Global
#4118 in USA
Share Price
$4.18
Change (1 day)
+0.24%
52-Week Range
$3.99 - $6.34
All Time High
$6.34
About

EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.… Read more